Dr. Christine M. Lovly MD, PHD?
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.
Dr. Christine M. Lovly MD, PHD
Hematologist-Oncologist | Hematology & Oncology
2601 Tvc Nashville TN, 37232Rating
1/5
About
Dr. Christine Lovly is a hematologist oncologist practicing in Nashville, TN. Dr. Lovly specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Washington Center / School of Medicine 2001
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Localization of human Cdc25C is regulated both by nuclear export and 14-3-3
- Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and
- Accurate mass-driven analysis for the characterization of protein phosphorylation. Study of the human Chk2 protein kinase.
- The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas.
- Identification of protein phosphorylation sites within Ser/Thr-rich cluster domains using site-directed mutagenesis and hybrid linear quadrupole ion trap Fourier transform ion cyclotron resonance mass spectrometry.
- Regulation of Chk2 ubiquitination and signaling through autophosphorylation of serine 379.
- Lung cancer in 2010: One size does not fit all.
- Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors.
- ALK mutations conferring differential resistance to structurally diverse ALK inhibitors.
- Escaping ALK inhibition: mechanisms of and strategies to overcome resistance.
- Strategies for overcoming EGFR resistance in the treatment of advanced-stage NSCLC.
- Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants.
- Translating genomic information into clinical medicine: lung cancer as a paradigm.
- A patient with metastatic lung adenocarcinoma harboring concurrent EGFR L858R, EGFR germline T790M, and PIK3CA mutations: the challenge of interpreting results of comprehensive mutational testing in lung cancer.
- Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.
Dr. Christine M. Lovly MD, PHD's Practice location
Practice At 2601 Tvc
2601 Tvc -Nashville, TN 37232Get Direction
New patients: 615-322-4916, 615-936-2000
Practice At 2220 Pierce Ave 777 Preston Research Building
2220 Pierce Ave 777 Preston Research -Nashville, TN 37232Get Direction
New patients: 212-746-5454
Fax: 212-746-6692
Dr. Christine M. Lovly MD, PHD's reviews
Write ReviewPatient Experience with Dr. Lovly
Dr. Christine M. Lovly MD, PHD has a rating of 1 out of 5 stars based on the reviews from 1 patient. FindaTopDoc has aggregated the experiences from real patients to help give you more insights and information on how to choose the best Hematologist-Oncologist in your area. These reviews do not reflect a providers level of clinical care, but are a compilation of quality indicators such as bedside manner, wait time, staff friendliness, ease of appointment, and knowledge of conditions and treatments.
Nearby Providers
![]()
Wendy K. Rathmell2220 Pierce Ave Nashville Tennessee 37232![]()
Dr. Igor Puzanov MD3601 The Vanderbilt Clinic Nashville TN 37232![]()
Dr. Michael Norbert Neuss M.D.2220 Pierce Avenue, Vanderbilt Ingram Cancer Center Nashville TN 37232![]()
Dr. Suneetha Amara M.D.3601 THE VANDERBILT CLINIC NASHVILLE TN 37232![]()
Dr. Olalekan Olaniyi Oluwole MD, MPH3601 THE VANDERBILT CLINIC NASHVILLE TN 37232![]()
Dr. Natalie Spradlin MD2601 Tvc Nashville TN 37232
Nearest Hospitals
958 ftSee direction
SAINT THOMAS MIDTOWN HOSPITALl
2000 CHURCH ST NASHVILLE TN 372364719 ftSee direction
SAINT THOMAS HOSPITAL FOR SPECIALTY SURGERYl
2011 MURPHY AVENUE NASHVILLE TN 372031.0 miSee direction
971 ftSee direction
SAINT THOMAS MIDTOWN HOSPITALl
2000 CHURCH ST NASHVILLE TN 372361.2 miSee direction
1.8 miSee direction